Finance

Lists
Why is 4884 down 6,48%?
Dive Deeper
4884:TYO
Kringle Pharma Inc
JP¥476,00
-6,48%
(-33,00) 1D
6 Nov., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4884...
Open
JP¥475
High
JP¥504
Low
JP¥451
Mkt. cap
4,09 mjd
Avg. vol.
405,63 k
Volume
517,60 k
52-wk high
JP¥741
52-wk low
JP¥287
EPS
-JP¥111
No. of employees
17
Open
JP¥475
High
JP¥504
Low
JP¥451
Mkt. cap
4,09 mjd
Avg. vol.
405,63 k
Volume
517,60 k
52-wk high
JP¥741
52-wk low
JP¥287
EPS
-JP¥111
No. of employees
17
News stories
From web sources and news partners
About Kringle Pharma Inc
CEOKiichi Adachi
Employees17
Founded21 Des. 2001
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
18,11 m
18,57 m
17,43 m
287,15 m
Cost of goods sold
-
-
-
70,39 m
Cost of revenue
-
-
-
70,39 m
Research and development expenses
681,00 m
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-492,41 m
218,48 m
333,52 m
335,44 m
Operating expense
188,59 m
218,48 m
333,52 m
335,44 m
Total operating expenses
188,59 m
218,48 m
333,52 m
405,83 m
Operating income
-170,48 m
-199,91 m
-316,09 m
-118,67 m
Other non operating income
-6,00 m
38,00 k
962,00 k
1,40 m
EBT including unusual items
-176,64 m
-201,48 m
-313,52 m
-114,70 m
EBT excluding unusual items
-176,64 m
-200,05 m
-313,95 m
-114,70 m
Income tax expense
-121,00 k
372,00 k
628,00 k
372,00 k
Effective tax rate
0,07%
-0,18%
-0,20%
-0,32%
Other operating expenses
-
-
-
-
Net income
-176,52 m
-201,85 m
-314,15 m
-115,08 m
Net profit margin
-974,87%
-1 086,97%
-1 802,35%
-40,07%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,00 m
-
Interest expense
-141,00 k
-
-
-
Net interest expenses
-141,00 k
-
1,00 m
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme